Morbidity and mortality of diabetic ketoacidosis with and without insulin pump care

Diabetes Technology and Therapeutics

Volumn 14, Issue 12, 2012, Pages 1149-1154

  Realsen, Jaime ^a   Goettle, Hannah ^a   Chase, H Peter ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN;

AGE DISTRIBUTION; BLOOD GLUCOSE MONITORING; DIABETIC KETOACIDOSIS; DISEASE ASSOCIATION; GLYCEMIC CONTROL; HEALTH CARE COST; HEALTH CARE DELIVERY; HEALTH INSURANCE; HUMAN; INFUSION PUMP; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN PUMP; INSULIN TREATMENT; MENTAL DISEASE; MORBIDITY; MORTALITY; PATIENT COMPLIANCE; PRIORITY JOURNAL; REVIEW; RISK FACTOR;

ADOLESCENT; ADULT; BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; DIABETIC KETOACIDOSIS; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INFANT; INSULIN; INSULIN INFUSION SYSTEMS; INSURANCE, HEALTH; MALE; MEDICATION ADHERENCE; MONITORING, AMBULATORY; MORBIDITY; RISK FACTORS;

EID: 84871002846     PISSN: 15209156     EISSN: 15578593     Source Type: Journal    
DOI: 10.1089/dia.2012.0161     Document Type: Review

References (35)

1. Rewers A, Chase HP, Mackenzie T, Walravens P, Roback M, Rewers M, Hamman RF, Klingensmith G: Predictors of acute complications in children with type 1 diabetes. JAMA 2002;287:2511-2518.
2. Shrestha SS, Barker L, Zhang P, Imperatore G: Medical expenditures associated with diabetes acute complications in privately insured US youth. Diabetes Care 2010;33:2617-2622.
3. Kim S: Burden of hospitalizations primarily due to uncontrolled diabetes. Diabetes Care 2007;30:1281-1283.
4. National Hospital Discharge Survey: 2004 annual summary with detailed diagnosis and procedure data. National Center for Health Statistics, Centers for Disease Control and Prevention. Vital and Health Statistics. Series 13, Number 162. October 2006. www.cdc.gov/nchs/data/series/sr-13/sr13-162.pdf (accessed July 2012).
5. Russo CA, Jiang HJ: Agency for Healthcare Research and Quality: Databases and related tools from the Healthcare Cost and Utilization Project (HCUP). Statistical brief #17: Hospital stays among patients with diabetes, 2004. www.hcup-us.ahrq.gov/reports/statbriefs/sb17.pdf (accessed July 2012).
6. Dunger DB, Sperling MA, Acerini CL, Bohn DJ, Daneman D, Danne TPA, Glaser NS, Hanas R, Hintz RL, Levitsky LL, Savage MO, Tasker RC, Wolfsdorf JI: European Society for Paediatric Endocrinology/Lawson Wilkins Pediatric Endocrine Society consensus statement on diabetic ketoacidosis on children and adolescents. Pediatrics 2004;113:e133Ye140.
7. Wolfsdorf J, Glaser N, Sperling MA: Diabetic ketoacidosis in infants, children, and adolescents: A consensus statement from the American Diabetes Association. Diabetes Care 2006;29:1150-1159.
8. Randall L, Peng L, Begovic J, Pitre N, Hudson M, Umpierrez D, Smiley D, Umpierrez G: Recurrent diabetic ketoacidosis in inner-city minority patients. Diabetes Care 2011;34:1891-1896.
9. Laing SP, Swerdlow AJ, Slater SD, Botha JL, Burden AC, Waugh NR, Smith AWM, Hill RD, Bingley PJ, Patterson CC, Qiao Z, Keen H: The British Diabetic Association Cohort Study, II: Cause-specific mortality in patients with insulintreated diabetes mellitus. Diabet Med 1999;16:466-471.
10. Dahlquist G, Kallen B: Mortality in childhood-onset type 1 diabetes. Diabetes Care 2005;28:2384-2387.
11. Patterson CC, Dahlquist G, Harjutsalo V, Joner G, Feltbower RG, Svensson J, Schober E, Gyurus E, Castell C, Urbonaite B, Rosenbauer J, Iotova V, Thorsson AV, Soltesz G: Early mortality in EURODIAB population-based cohorts of type 1 diabetes diagnosed in childhood since 1989. Diabetologia 2007;50:2439-2442.
12. Secrest AM, LaPorte RE, Becker DJ, Orchard TJ, Kelsey SF: All-cause mortality trends in a large population-based cohort with long-standing childhood-onset type 1 diabetes: The Allegheny County type 1 diabetes registry. Diabetes Care 2010;33:2573-2579.
13. Weston PJ, Gill GV: Is undetected autonomic dysfunction responsible for sudden death in type 1 diabetes mellitus The 'dead in bed' syndrome revisited. Diabet Med 1999;16:626-631.
14. Phillip M, Danne T, Battelino T, Kaufman F, Rodriguez H: Use of insulin pump therapy in the pediatric age group: Consensus statement from the European Society for Paediatric Endocrinology, the Lawson Wilkins Pediatric Endocrine Society, and the International Society for Pediatric and Adolescent Diabetes, endorsed by the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2007;30:1653-1662.
15. Hanas R, Lindgren F, Lindglad B: A 2-yr national population study of pediatric ketoacidosis in Sweden: Predisposing conditions and insulin pump use. Pediatr Diabetes 2009;10:33-37.
16. Tamborlane WV, Sikes KA: Insulin therapy in children and adolescents. Endocrinol Metab Clin North Am 2012;41: 145-160.
17. Weissberg-Benchell J, Antisdel-Lomaglio J, Seshadri R: Insulin pump therapy: A meta-analysis. Diabetes Care 2003;26:1079-1087.
18. Berghaeuser MA, Kapellen T, Heidtmann B, Haberland H, Klinkert C, Holl RW: Continuous subcutaneous insulin infusion in toddlers starting at diagnosis of type 1 diabetes mellitus. A multicenter analysis of 104 patients from 63 centres in Germany and Austria. Pediatr Diabetes 2008;9:590-595.
19. Scrimgeour L, Cobry E, McFann K, Burdick P, Weimer C, Slover R, Chase HP: Improved glycemic control after longterm insulin pump use in pediatric patients with type 1 diabetes. Diabetes Technol Ther 1007;9:421-428.
20. Willi SW: T1D exchange. Diabetic ketoacidosis and hypoglycemia in relation to pump and sensor use [abstract]. Presented at the Advanced Technologies and Treatments for Diabetes Meeting, Barcelona, Spain, February 8, 2012.
21. Attia N, Holcombe J, Jones TW, Tamborlane WV: Comparison of human regular and lispro insulins after interruption of continuous subcutaneous insulin infusion and in the treatment of acutely decompensated IDDM. Diabetes Care 1998;21:817-821.
22. Buckingham B, Caswell K, Chase HP, Wilkinson J, Dassau E, Cameron F, Cobry E, Lee H, Clinton P, Bequette BW, Gage V, Doyle FJ: Prevention of nocturnal hypoglycemia using predictive alarm algorithms and insulin pump suspension. Diabetes Care 2010;33:1013-1017.
23. Orsini-Federici M, Akwi JA, Canonico V, Celleno R, Ferolla P, Pippi R, Tassi C, Timi A, Benedetti MM: Early detection of insulin deprivation in continuous subcutaneous insulin infusion-treated patients with type 1 diabetes. Diabetes Technol Ther 2006;1:67-75.
24. Guerci B, Fougnot S, Benichou M, Franck P, Floriot M, Crouin P, Bohme P: Accuracy of an electrochemical sensor for measuring capillary blood ketones by fingerstick samples during metabolic deterioration after continuous subcutaneous insulin infusion interruption in type 1 diabetic patients. Diabetes Care 2003;26:1137-1141.
25. Diabetes Research in Children Network (DirecNet) Study Group: Prevention of hypoglycemia during exercise in children with type 1 diabetes by suspending basal insulin. Diabetes Care 2006;29:2200-2204.
26. Castillo MJ, Sheen AJ, Lefebvre PJ: The degree/rapidity of the metabolic deterioration following interruption of a continuous subcutaneous insulin infusion is influenced by the prevailing blood glucose level. J Clin Endocrinol Metab 1996;81:1975-1978.
27. Danne T, Kordonouri O, Holder M, Haberland H, Golembowski S, Remus K, Bla sig S, Wadien T, Zierow S, Hartmann R, Thomas A: Prevention of hypoglycemia by using low glucose suspend function in sensor-augmented pump therapy. Diabetes Technol Ther 2011;13:1129-1134.
28. Choudhary P, Kerr D, Shin J, Shaw JAM, Wang Y, Pickup JC, Evans ML, Amiel SA, Hammond PJ: Insulin pump therapy with automated insulin suspension in response to hypoglycemia: Reduction in nocturnal hypoglycemia in those at greatest risk. Diabetes Care 2011;34:2023-2025.
29. Agrawal P, Welsh JB, Kannard B, Askari S, Yang Q, Kaufman FR: Usage and effectiveness of the low glucose suspend feature of the Medtronic Paradigm Veo insulin pump. J Diabetes Sci Technol 2011;5:1127-1141.
30. Cope JU, Morrison AE, Samuels-Reid J: Adolescent use of insulin and patient-controlled analgesia pump technology: A 10-year food and drug administration retrospective study of adverse events. Pediatrics 2008;121:e1133Ye1138.
31. The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329:977-986.
32. The Diabetes Control and Complications Trial Research Group: The adverse events and their association with treatment regimens in the Diabetes Control and Complications Trial. Diabetes Care 1995;18:1415-1427.
33. Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group: Continuous glucose monitoring and intensive treatment of type 1 diabetes. N Engl J Med 2008;359:464-476.
34. Bergenstal RM, Tamborlane WV, Ahmann A, Buse JB, Dailey G, Davis SN, Joyce C, Peoples T, Perkins BA, Welsh JB, Willi SM, Wood MA; STAR 3 Study Group: Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes. N Engl J Med 2010;363:311-320.
35. Chase HP, Maahs DM: Understanding Diabetes, 12th ed. Denver: Children's Diabetes Foundation, 2011.